Will sublingual immunotherapy offer benefit for asthma? (Q38136106)

29 August 2017

title

Will sublingual immunotherapy offer benefit for asthma? (English)

1 reference

29 August 2017

1 reference

5

Giovanni Passalacqua

1 reference

29 August 2017

Giorgio Walter Canonica

4

object named as

Giorgio Walter Canonica

1 reference

29 August 2017

Carlos E Baena-Cagnani

1

object named as

Carlos E Baena-Cagnani

1 reference

29 August 2017

author name string

Désirée Larenas-Linnemann

2

1 reference

29 August 2017

Alvaro Teijeiro

3

1 reference

29 August 2017

publication date

1 December 2013

1 reference

Current Allergy and Asthma Reports

29 August 2017

published in

1 reference

29 August 2017

volume

13

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

571-579

1 reference

Pediatric asthma and development of atopy

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Asthma severity, atopic status, allergen exposure and quality of life in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Evidence of effect of subcutaneous immunotherapy in children: complete and updated review from 2006 onward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Sublingual immunotherapy in children: complete and updated review supporting evidence of effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Systematic reviews of sublingual immunotherapy (SLIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Tolerability and efficacy of house dust mite AIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Safety of ultra-rush titration of sublingual immunotherapy in asthmatic children with tree-pollen allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

International consensus on (ICON) pediatric asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Efficacy of sublingual specific immunotherapy in patients with respiratory allergy toAlternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-013-0385-5

Effect of AIT in children including potential to prevent the development of asthma

21 January 2018

1 reference

12 December 2020

Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts

1 reference

12 December 2020

Medical management and sublingual immunotherapy practices in patients with house dust mite-induced respiratory allergy: a retrospective, observational study.

1 reference

12 December 2020

Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey

1 reference

12 December 2020

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

1 reference

12 December 2020

Randomized open comparison of montelukast and sublingual immunotherapy as add-on treatment in moderate persistent asthma due to birch pollen.

1 reference

12 December 2020

Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study

1 reference

12 December 2020

Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review

1 reference

12 December 2020

British guidelines on the management of asthma: what's new for 2011?

1 reference

12 December 2020

Observational study of the safety of an ultra-rush sublingual immunotherapy regimen to treat rhinitis due to house dust mites

1 reference

12 December 2020

House Dust Mite Sublingual Immunotherapy

1 reference

12 December 2020

Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen

1 reference

12 December 2020

Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children

1 reference

12 December 2020

Clinical relevance of non-grass pollens respiratory allergies in Italy and effects of specific sublingual immunotherapy: The Rainbow Trial, a multicentre 3-year prospective observational study

1 reference

12 December 2020

Injection allergen immunotherapy for asthma

1 reference

12 December 2020

Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: A long-term (13-year) retrospective study in real life

1 reference

12 December 2020

Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite

1 reference

12 December 2020

Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial

1 reference

12 December 2020

SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

1 reference

12 December 2020

Allergen immunotherapy for asthma

1 reference

12 December 2020

Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.

1 reference

12 December 2020

Summary of the 2008 BTS/SIGN British Guideline on the management of asthma.

1 reference

12 December 2020

Sublingual immunotherapy for Alternaria-induced allergic rhinitis: a randomized placebo-controlled trial

1 reference

12 December 2020

Children passive smoking jeopardises the efficacy of standard anti-allergic pharmacological therapy, while sublingual immunotherapy withstands

1 reference

12 December 2020

The natural course of sensitisation and atopic disease in infancy and childhood

1 reference

12 December 2020

Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study

1 reference

12 December 2020

Characteristics of patients with respiratory allergy in France and factors influencing immunotherapy prescription: a prospective observational study (REALIS).

1 reference

12 December 2020

Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study

1 reference

12 December 2020

Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial

1 reference

12 December 2020

10.1007/S11882-013-0385-5

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1031323122

0 references

1 reference